1 Meulenbelt I, "Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study" 65 : 360-365, 2006
2 Manicourt DH, "Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions" 42 : 1159-1167, 1999
3 Sellam J, "The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis" 6 : 625-635, 2010
4 Hayami T, "The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model" 50 : 1193-1206, 2004
5 Lotz M, "The role of nitric oxide in articular cartilage damage" 25 : 269-282, 1999
6 Fernandes JC, "The role of cytokines in osteoarthritis pathophysiology" 39 : 237-246, 2002
7 Karsdal MA, "The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study" 18 : 150-159, 2010
8 Sondergaard BC, "The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model" 56 : 2674-2678, 2007
9 Ofluoglu D, "The effect of calcitonin on beta- endorphin levels in postmenopausal osteoporotic patients with back pain" 26 : 44-49, 2007
10 Karsdal MA, "Should subchondral bone turnover be targeted when treating osteoarthritis?" 16 : 638-646, 2008
1 Meulenbelt I, "Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study" 65 : 360-365, 2006
2 Manicourt DH, "Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions" 42 : 1159-1167, 1999
3 Sellam J, "The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis" 6 : 625-635, 2010
4 Hayami T, "The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model" 50 : 1193-1206, 2004
5 Lotz M, "The role of nitric oxide in articular cartilage damage" 25 : 269-282, 1999
6 Fernandes JC, "The role of cytokines in osteoarthritis pathophysiology" 39 : 237-246, 2002
7 Karsdal MA, "The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study" 18 : 150-159, 2010
8 Sondergaard BC, "The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model" 56 : 2674-2678, 2007
9 Ofluoglu D, "The effect of calcitonin on beta- endorphin levels in postmenopausal osteoporotic patients with back pain" 26 : 44-49, 2007
10 Karsdal MA, "Should subchondral bone turnover be targeted when treating osteoarthritis?" 16 : 638-646, 2008
11 Di Nino DL, "Positive regulation of endochondral cartilage growth by perichondrial and periosteal calcitonin" 144 : 1979-1983, 2003
12 van Baar ME, "Pain and disability in patients with osteoarthritis of hip or knee: the relationship with articular, kinesiological and psychological characteristics" 25 : 125-133, 1998
13 Lyritis GP, "Pain Relief From Nasal Salmon Calcitonin I . n Osteoporotic Vertebral Crush Fractures" 275 : 112-114, 1997
14 Manicourt DH, "Oral salmon calcitonin reduces Lequesne’s algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis" 54 : 3205-3211, 2006
15 Bagger YZ, "Oral salmon calcitonin induced suppression of urinary collogen type II degradation in postmenapausal women: A new potential treatment of osteoarthritis" 37 : 425-430, 2005
16 Ito A, "Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin: participation of 5-HT1A-like receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord" 20 : 6302-6308, 2000
17 Sondergaard BC, "Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes" 11 : 62-, 2010
18 Dam EB, "Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI" 17 : 384-389, 2009
19 Petrella RJ, "Home based exercise therapy for older patients with knee osteoarthritis: a randomized clinical trial" 27 : 2215-2221, 2000
20 Franchimont P, "Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters" 69 : 259-266, 1989
21 Evcik D, "Effectiveness of a home-based exercise therapy and walking program on osteoarthritis of the knee" 22 : 103-106, 2002
22 Badurski J, "Comparative analysis of three treatment regimens for treating gonarthritis with calcitonin, naproxen and flavonoids based on EULAR criteria and visual analogue scale (VAS)" 50 : 37-40, 1995
23 Meulenbelt I, "Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study" 15 : 379-385, 2007
24 Suzuki H, "Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts" 137 : 4685-4690, 1996
25 Karsdal MA, "Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?" 14 : 617-624, 2006
26 Shyu JF, "Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities" 40 : 1329-1342, 2007
27 Sondergaard BC, "Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes" 14 : 759-768, 2006
28 Takayama B, "An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats" 9 : 164-, 2008
29 Bredella MA, "Accuracy of T2-weighted fast spinecho MR imaging with fat saturation in detecting cartilage defects in the knee: comparison with arthroscopy in 130 patients" 172 : 1073-1080, 1999
30 Reijman M, "A new marker for osteoarthritis: cross-sectional and longitudinal approach" 50 : 2471-2478, 2004